ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

KZIA Kazia Therapeutics Ltd

0.23
-0.00007 (-0.03%)
18 Jun 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 206,796
Bid Price 0.23
Ask Price 0.26
News -
Share Name Share Symbol Market Stock Type
Kazia Therapeutics Ltd KZIA NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.00007 -0.03% 0.23 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.229 0.2285 0.2496 0.23 0.230065
Trades Shares Traded VWAP Financial Volume Average Volume
462 206,796  0.2367295  48,955 -
Last Trade Type Quantity Price Currency
09:54:50 10  0.2476 USD

Kazia Therapeutics Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 228.03M - 0 -20.47M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Kazia Therapeutics

Date Time Source Heading
05/6/202414:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
05/6/202406:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
29/5/202422:55Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign..
24/5/202404:41PR Newswire (US)Kazia Granted 180-Day Extension by Nasdaq to Meet the..
23/5/202421:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
23/5/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/5/202406:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
18/5/202406:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/5/202422:45PR Newswire (US)KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801..
21/3/202423:52PR Newswire (US)Kazia Therapeutics licenses paxalisib to Sovargen for..
13/3/202423:00PR Newswire (US)Kazia announces presentation of new data at AACR Annual..
22/2/202408:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]

KZIA Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Your Recent History

Delayed Upgrade Clock